Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.

Experimental biology and medicine (Maywood, N.J.) - 1 Jan 2022

Chen Qiangda, Pu Ning, Yin Hanlin, Zhang Jicheng, Zhao Guochao, Lou Wenhui, Wu Wenchuan

Abstract excerpt

Although several altered metabolic genes have been identified to be involved in the tumorigenesis and advance of pancreatic cancer (PC), their prognostic values remained unclear. The purpose of this study was to explore new targets and establish a metabolic signature to predict prognosis and chemotherapy response for optimal individualized treatment. The expression data of PC patients from two independent cohorts...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Pancreatic Neoplasms

Share to Risk Factors

Share to Survival Rate

Share to Transcriptome

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34632851
DOI: 10.1177/15353702211049220
PMCID: PMC8777477

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.PMID 34632851Read ↗

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.Semantic proximity Read ↗

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity Read ↗

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionSemantic proximity Read ↗

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic CancerSemantic proximity Read ↗

A Novel BCAA-catabolism Related Gene Signature for Overall Survival Prediction of Pancreatic CarcinomaSemantic proximity Read ↗

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read ↗

The Prognostic Value of Metabolic Genes in Gastric AdenocarcinomaSemantic proximity Read ↗

Metabolic Reprogramming：Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancerSemantic proximity Read ↗

Hypoxia- and Lactate Metabolism-Associated Prognostic and Therapeutic Signature in Pancreatic CancerSemantic proximity Read ↗

Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung AdenocarcinomaSemantic proximity Read ↗

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.